Is Losing Hair a Side Effect of Mounjaro?

Last reviewed: July 12, 2026

Last updated: July 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro (tirzepatide) has become one of the most prescribed GLP-1 receptor agonists for weight management, but reports of hair loss have raised questions among potential users. Clinical trials for tirzepatide show that alopecia occurs in fewer than 1% of participants, yet rapid weight loss itself—not the medication—may trigger temporary hair shedding in some individuals. PlexusDx offers tirzepatide therapy starting at $289/month through licensed compounding pharmacies, and understanding the real science behind weight-loss-related hair changes helps you distinguish genuine side effects from expected metabolic shifts.

Does Mounjaro Actually Cause Hair Loss?

Mounjaro's clinical trial data does not identify hair loss as a direct pharmacological side effect of tirzepatide itself. The medication works by activating GLP-1 and GIP receptors in the brain and pancreas to reduce appetite and improve blood sugar control—mechanisms that do not directly target hair follicles. However, the rapid weight loss that Mounjaro enables can trigger a temporary hair-shedding condition called telogen effluvium, where increased physical stress shifts more hair follicles into their shedding phase simultaneously.

Telogen effluvium is a reversible condition that typically resolves within 3 to 6 months as your body adapts to its new weight and nutritional demands stabilize. It is distinct from androgenetic alopecia (pattern baldness), which is driven by genetic sensitivity to DHT rather than medication. PlexusDx patients who experience noticeable shedding during their first months of tirzepatide therapy are encouraged to monitor hair density and report changes to their care team, since nutritional support and slower dose escalation can reduce the severity of this temporary response.

Why Weight Loss Can Trigger Temporary Hair Shedding

When your body loses weight rapidly—whether through diet, GLP-1 therapy, or other means—it experiences a form of physiological stress. Hair growth requires stable supplies of protein, iron, zinc, and B vitamins; sudden caloric restriction or increased metabolic demand can redirect these nutrients toward essential functions, temporarily pushing hair follicles out of their growth phase. This process is not harmful or permanent; it is your body's normal adaptation to changing energy availability.

Patients starting Mounjaro or other tirzepatide formulations should prioritize adequate protein intake (aim for 80–100 grams daily), maintain iron and B12 levels through diet or supplementation, and ensure consistent micronutrient absorption during rapid weight loss. PlexusDx recommends discussing nutritional strategies with your provider before or early in treatment, since proactive dietary planning can minimize the intensity and duration of telogen effluvium. Studies show that patients who maintain stable protein and micronutrient levels experience less noticeable hair shedding during GLP-1 therapy.

What the Clinical Data Actually Shows About Tirzepatide and Hair

The SURPASS trial series, which evaluated tirzepatide in over 10,000 participants across multiple studies, reported alopecia (hair loss) in fewer than 1% of treated patients—a rate comparable to placebo groups. Notably, the trial populations were carefully monitored, and participants received nutritional guidance throughout the study period. Real-world reports of hair shedding in online communities may reflect selection bias (people experiencing side effects are more likely to post) rather than the true frequency of the phenomenon.

Importantly, most reported cases of hair changes during GLP-1 therapy are telogen effluvium—a temporary shedding that does not indicate permanent follicle damage. Hair follicles remain viable and resume normal growth cycles once weight stabilizes and nutritional status improves. PlexusDx patients benefit from transparent communication about this distinction: if you notice increased shedding, it is typically a sign that your body needs better nutritional support during weight loss, not that tirzepatide is damaging your hair.

Strategies to Minimize Hair Shedding During Tirzepatide Treatment

Proactive nutritional management is the most effective way to prevent or reduce telogen effluvium during GLP-1 therapy. Ensure daily protein intake meets or exceeds 0.8 grams per pound of target body weight, include iron-rich foods (red meat, legumes, fortified cereals), and consider supplementing with a high-quality B-complex vitamin and biotin. Staying hydrated, managing stress through sleep and exercise, and avoiding rapid dose escalation all support stable hair health during treatment.

PlexusDx tirzepatide therapy is available through licensed 503A compounding pharmacies in all 50 states, and your care team can work with you to pace your dose increases in a way that allows your body to adapt metabolically. If you experience noticeable hair shedding after starting treatment, report it early so your provider can assess nutritional status, slow your dose progression if appropriate, and monitor whether the shedding resolves as expected. Most patients who maintain consistent protein and micronutrient levels report minimal to no hair changes.

Genetic Factors and Individual Susceptibility to Hair Loss

Some individuals may be genetically predisposed to experience more pronounced telogen effluvium during periods of metabolic stress due to variations in peptide signaling pathways and nutrient metabolism. PlexusDx Precision Peptide Genetic Test identifies key genetic variants—including those affecting nutrient absorption and metabolic stress response—that can inform personalized treatment strategies. Understanding your genetic profile helps your care team anticipate your individual risk and recommend targeted nutritional interventions before hair shedding becomes noticeable.

The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment and maps 14 metabolic pathways across 49 peptides, providing 150+ genetic insights relevant to your response to tirzepatide and other GLP-1 therapies. Patients with genetic markers associated with higher nutrient needs or stress-sensitive hair follicles can benefit from proactive supplementation and monitoring, turning genetic information into a practical advantage during weight loss treatment.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is hair loss listed as a side effect of Mounjaro in official prescribing information?

Alopecia is not listed as a common side effect of tirzepatide in clinical trial data; it occurs in fewer than 1% of patients and at rates similar to placebo. What many patients experience is telogen effluvium—temporary, stress-induced shedding caused by rapid weight loss itself, not the medication. This distinction is important: Mounjaro does not directly damage hair follicles or cause permanent baldness.

How long does hair shedding last during GLP-1 therapy?

Telogen effluvium typically resolves within 3 to 6 months as your body adapts to its new weight and nutritional demands stabilize. Hair follicles remain healthy and resume their normal growth cycle once metabolic stress decreases. Early nutritional intervention and consistent protein intake can reduce both the severity and duration of shedding.

Can I prevent hair loss while taking tirzepatide?

Yes. Maintain daily protein intake of 80–100 grams or more, ensure adequate iron and B vitamins, stay hydrated, manage stress, and sleep 7–9 hours nightly. Work with your PlexusDx provider to pace your dose increases gradually so your body adapts metabolically without experiencing acute nutritional stress. Most patients who prioritize nutrition during treatment experience minimal hair changes.

Is the hair shedding from tirzepatide permanent?

No. Tirzepatide does not permanently damage hair follicles. The shedding associated with rapid weight loss (telogen effluvium) is reversible; hair regrows once your weight and nutritional status stabilize. Unlike pattern baldness, which is genetic and permanent, weight-loss-related shedding is a temporary response that resolves on its own or with nutritional support.

How can the PlexusDx Precision Peptide Genetic Test help with hair loss concerns?

The Precision Peptide Genetic Test identifies genetic variants affecting nutrient metabolism and metabolic stress response, allowing your care team to anticipate your individual risk for telogen effluvium. For $99 after your first treatment month, the test provides 150+ genetic insights that inform personalized supplementation and dosing strategies, helping minimize hair changes and optimize your overall response to tirzepatide therapy.

Should I stop taking Mounjaro if I notice hair shedding?

No. Telogen effluvium during GLP-1 therapy is temporary and manageable with nutritional support; stopping treatment is not necessary. Contact your PlexusDx care team to discuss your hair changes, optimize your protein and micronutrient intake, and ensure your dose progression is appropriate for your body's adaptation rate. Most patients continue treatment successfully with enhanced nutritional planning.

Related Reading

• Mounjaro For Losing Weight
• Mounjaro Side Effects Plexusdx
• Mounjaro Side Effects
• Hers Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.